| Tubulo-interstitial nephritis, pyelonephritis, and urinary tract infections |
Interventions to improve professional adherence to guidelines for prevention of device-related infections (R) |
| |
Mechanical dilatation of the cervix at non-labour caesarean section for reducing postoperative morbidity (R) |
| |
Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section (R) |
| |
Traditional suburethral sling operations for urinary incontinence in women (R) |
| |
Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures (R) |
| |
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers (R) |
| |
Rituximab for relapsing-remitting multiple sclerosis (R) |
| |
Beta lactam antibiotic monotherapy versus beta lactam -aminoglycoside antibiotic combination therapy for sepsis (R) |
| |
Habit retraining for the management of urinary incontinence in adults (R) |
| |
Preoperative skin antiseptics for preventing surgical wound infections after clean surgery (R) |
| |
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding (R) |
| |
Antimicrobial therapy for chronic bacterial prostatitis (R) |
| |
Cyanoacrylate microbial sealants for skin preparation prior to surgery (R) |
| |
Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery (R) |
| |
Interventions to improve antibiotic prescribing practices in ambulatory care (R) |
| |
Teriflunomide for multiple sclerosis (R) |
| |
Laquinimod for multiple sclerosis (R) |
| |
Mitoxantrone for multiple sclerosis (R) |
| |
Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1 (R) |
| |
Surgical approach to hysterectomy for benign gynecological disease (R) |
| |
Interventions for preventing mastitis after childbirth (R) |
| |
Laparoscopy versus laparotomy for benign ovarian tumor (R) |
| |
Valproate preparations for agitation in dementia (R) |
| |
Regional versus general anesthesia for caesarean section (R) |
| |
Interventions for promoting the initiation of breastfeeding (R) |
| |
Protocolized versus non- protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients (R) |
| |
In-hospital care pathways for stroke (R) |
| |
Schedules for home visits in the early postpartum period (R) |
| |
Short term benefits for laparoscopic colorectal resection (R) |
| |
Diaphragm versus diaphragm with spermicides for contraception (R) |
| |
Cervical cap versus diaphragm for contraception (R) |
| Kidney and other urinary organ cancers |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer (R) |
| |
Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer (R) |
| |
Bisphosphonates and other bone agents for breast cancer (R) |
| |
Interventions for preventing non-melanoma skin cancers in high-risk groups (R) |
| |
Perioperative blood transfusions and recurrence of colorectal cancer (R) |
| |
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer (R) |
| |
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer (R) |
| |
Immunosuppressive T-cell antibody induction for heart transplant recipients (R) |
| |
Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix (R) |
| |
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients (R) |
| |
HMG CoA reductase inhibitors (statins) for dialysis patients (R) |
| |
Urinary diversion and bladder reconstruction /replacement using intestinal segments for intractable incontinence or following cystectomy (R) |
| |
Pharmacological interventions for pruritus in adult palliative care patients (R) |
| |
Homocysteine-lowering interventions for preventing cardiovascular events (R) |
| |
HMG CoA reductase inhibitors (statins ) for kidney transplant recipients (R) |
| |
Vitamin D supplementation for prevention of mortality in adults (R) |
| |
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men (R) |
| |
Antibody induction therapy for lung transplant recipients (R) |
| |
First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma , a systematic review of controlled studies (R) |
| |
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis (R) |
| |
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients (R) |
| |
Bisphosphonates in multiple myeloma: a network meta-analysis (R) |
| |
Darbepoetin for the anemia of chronic kidney disease (R) |
| |
Selenium for preventing cancer (R) |
| |
Hyperbaric oxygenation for tumor sensitization to radiotherapy (R) |
| |
Adjuvant radiotherapy following radical prostatectomy for prostate cancer (R) |
| |
Exenterative surgery for recurrent gynecological malignancies (R) |
| |
Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer (R) |
| |
Laparoscopy versus laparotomy for the management of early stage endometrial cancer (R) |
| |
Laparoscopic versus open total mesorectal excision for rectal cancer (R) |
| |
Adjuvant radiotherapy for stage I endometrial cancer (R) |
| |
Cryotherapy for localized prostate cancer (R) |
| |
Spinal cord stimulation for cancer -related pain in adults (R) |
| |
Chemoradiation for advanced primary vulval cancer (R) |
| |
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer (R) |
| |
Surgical management for upper urinary tract transitional cell carcinoma (R) |
| |
Cholecystectomy for patients with silent gallstones (R) |
| |
Drugs for treating urinary schistosomiasis (R) |
| |
Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis (R) |
| |
Cranberries for preventing urinary tract infections (R) |
| |
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases (R) |
| |
Conservative management for postprostatectomy urinary incontinence (R) |
| |
Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery (R) |
| |
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men (R) |
| Urolithiasis |
Pegloticase for chronic gout (R) |
| |
Fluids and diuretics for acute ureteric colic (R) |
| |
Vitamin D supplementation for prevention of mortality in adults (R) |
| |
Chinese medicinal herbs for cholelithiasis (R) |
| |
Thyroid hormones for acute kidney injury (R) |
| |
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men (R) |
| Male infertility |
Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in couples with non-male subfertility (R) |
| |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis (R) |
| |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis (R) |
| |
Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility (R) |
| |
Vasectomy occlusion techniques for male sterilization (R) |
| |
Steroid hormones for contraception in men (R) |
| Benign prostatic hyperplasia |
Interventions for chronic abacterial prostatitis (R) |
| Prostate cancer |
Interventions for improving the adoption of shared decision making by healthcare professionals (R) |
| Testicular cancer |
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease (R) |
| Bladder cancer |
Cholecystectomy for patients with silent gallstones (R) |
| |
Hyperbaric oxygenation for tumor sensitization to radiotherapy (R) |
| |
Drugs for treating urinary schistosomiasis (R) |
| |
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer (R) |
| |
Adjuvant radiotherapy for stage I endometrial cancer (R) |
| |
Laparoscopy versus laparotomy for the management of early stage endometrial cancer (R) |
| |
Selenium for preventing cancer (R) |
| |
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases (R) |
| |
Chemoradiation for advanced primary vulval cancer (R) |
| |
Laparoscopic versus open total mesorectal excision for rectal cancer (R) |
| |
Spinal cord stimulation for cancer-related pain in adults (R) |
| Hydrocele due to lymphatic filariasis |
Albendazole for lymphatic filariasis (R) |
| |
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis (R) |
| Dysuria/bladder pathology/hydronephrosis due to schistosomiasis |
Metrifonate for Alzheimer's disease (R) |
| |
Drugs for treating Schistosoma mansoni infection (R) |
